Theratechnologies Stock Quote THTX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.35

Bid

1.03

Ask

1.38

Volume

26,212

1.25 Day's Range 1.38

0.88 52 Week Range 17.8396

Market Cap

62.073M

Previous Close

1.24

Open

1.38

Last Trade

1.33

Last Trade Time

Financial Volume

$ 35,693

VWAP

1.3617

Average Volume (3m)

29,363

Shares Outstanding

45,980,019

Dividend Yield

PE Ratio

-2.59

Earnings Per Share (EPS)

-0.52

Revenue

81.76M

Net Profit

-23.96M

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization... Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.theratech.com

Headquarters

Quebec City, Quebec, Can

Founded

Theratechnologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker THTX. The last closing price for Theratechnologies was $1.24. Over the last year, Theratechnologies shares have traded in a share price range of $ 0.88 to $ 17.8396.

Theratechnologies currently has 45,980,019 shares outstanding. The market capitalization of Theratechnologies is $57.02 million. Theratechnologies has a price to earnings ratio (PE ratio) of -2.59.

Theratechnologies to Present at Upcoming Investor Conferences in September

MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024

Q2 revenue of $22 million represents +25% growth year-over-yearPositive net income of $1 million realized with Adjusted EBITDA1 of $5.5 million Fiscal 2024 revenue guidance confirmed between $87...

U.S. Index Futures Climb; Oil Prices Recover

U.S. index futures are up in pre-market trading this Wednesday. At 6:08 AM, Dow Jones (DOWI:DJI) futures rose 6 points, or 0.02%. S&P 500 futures advanced 0.14%, and Nasdaq-100 futures gained...

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Poster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Reports on its Annual Meeting of Shareholders

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	1.35	1.41	1.18	17028	1.28560902	CS
4	0.04	3.0534351145	1.31	1.74	1.18	39644	1.43577938	CS
12	0.1	8	1.25	1.74	1.08	29363	1.39675377	CS
26	-1.04	-43.5146443515	2.39	2.58	0.88	81183	1.49341549	CS
52	-13.49	-90.9029649596	14.84	17.8396	0.88	122119	5.69073064	CS
156	-13.81	-91.0949868074	15.16	17.8396	0.88	154537	8.5015631	CS
260	0	0	0	1.38	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NOVVUNova Vision Acquisition Corporation	$ 41.00 (207.35%)	17.4k
NOVVNova Vision Acquisition Corporation	$ 37.0001 (200.08%)	202.75k
SMXSMX Security Matters Public Company	$ 5.85 (138.78%)	49.72M
OMICSingular Genomics Systems Inc	$ 12.38 (119.12%)	2.72M
TILInstill Bio Inc	$ 84.75 (82.41%)	3.76M
GSIWGarden Stage Ltd	$ 2.9693 (-75.66%)	4.24M
UPCUniverse Pharmaceuticals Inc	$ 0.55 (-67.07%)	30.45M
VMARVision Marine Technologies Inc	$ 0.77 (-48.67%)	34.54M
PRLDPrelude Therapeutics Inc	$ 2.775 (-42.55%)	2.49M
CNEYCN Energy Group Inc	$ 0.4335 (-37.17%)	5.06M
NVDANVIDIA Corporation	$ 119.10 (-0.03%)	238.43M
XXII22nd Century Group Inc	$ 0.3447 (28.00%)	183.73M
IMRXImmuneering Corporation	$ 2.02 (41.26%)	136.36M
SQQQProShares UltraPro Short QQQ	$ 8.17 (-1.33%)	127.78M
MULNMullen Automotive Inc	$ 0.1328 (-20.48%)	120.81M